Skip to main content

Table 1 Clinical characteristics of RA-a and RA-r patients

From: Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis

Variable RA-a (n = 17) RA-r (n = 17)
Age, years, median (IQR) 57 (54 to 63.5) 53.5 (44 to 57.5)
Female, n (%) 16 (94) 13 (76.5)
Disease duration, years, median (IQR) 12.5 (6 to 20) 10 (6 to 16.5)
Disease activity in 28 joints (DAS28) score, median (IQR) 3.4 (3 to 4.4) 2 (1.7 to 2.4)
Rheumatoid factor-positive, n(%) 16 (94) 16 (94)
Anti-citrullinated peptide antibodies-positive, n (%) 14 (82) 14 (82)
Methotrexate, n (%) 17 (100) 17 (100)
Prednisone ≤5 mg/day, n (%) 11 (65) 4 (24)
Leflunomide, n (%) 2 (12) 3 (18)
Hydroxychloroquine, n (%) 2 (12) 4 (24)
  1. RA-a: RA patients with active disease (DAS28 >2.6); RA-r: RA patients in remission (DAS28 <2.6) [31].